Biomarker based immunoassays have emerged as a cornerstone of modern clinical diagnostics, enabling precise detection and quantification of biological markers associated with diseases. These assays play a pivotal role in early disease identification, therapeutic monitoring, and personalized treatment strategies. In an era where precision medicine is becoming the global standard, biomarker-based...
The global botulinum toxin CDMO market size was estimated at USD 2.5 billion in 2025 and is projected to reach USD 5.8 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market is experiencing significant momentum as pharmaceutical and biotechnology companies increasingly rely on contract development and manufacturing organizations (CDMOs) to streamline production, enhance...
According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032.
cGMP process development represents the critical discipline of systematically designing,...
Viral Vector and Plasmid DNA Manufacturing Market Expands with Rising Demand for Gene Therapy and Advanced Biologics
The global Viral Vector and Plasmid DNA Manufacturing Market is experiencing robust growth as the biopharmaceutical industry accelerates the development of gene therapies, cell therapies, and next-generation vaccines. Growing investments in precision medicine, increasing...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek